Division of Gastroenterology and Hepatology, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.
Division of Gastroenterology and Hepatology, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.
Clin Gastroenterol Hepatol. 2022 Jul;20(7):1606-1608.e2. doi: 10.1016/j.cgh.2021.12.013. Epub 2021 Dec 9.
Coronavirus disease 2019 (COVID-19) vaccines are recommended for all patients with inflammatory bowel disease (IBD). Patients with IBD historically have had low vaccine uptake relative to the general population. However, a recent survey suggested a rate higher than that of the general population with regard to COVID-19 vaccine intent among the IBD population. Their study was limited being that 96% of the patients surveyed identified as White, and 88% had attained a bachelor's degree or higher level of education. Therefore, these findings may not be representative of the IBD population as a whole. Previous studies have indeed identified disparities in influenza vaccine uptake within the IBD population..
新型冠状病毒病 2019（COVID-19）疫苗推荐用于所有炎症性肠病（IBD）患者。与一般人群相比，IBD 患者的疫苗接种率历来较低。然而，最近的一项调查表明，在 IBD 人群中，COVID-19 疫苗接种意愿的比例高于一般人群。他们的研究存在局限性，因为接受调查的患者中有 96%自认为是白人，88%已获得学士学位或更高学历。因此，这些发现可能不能代表整个 IBD 人群。之前的研究确实发现 IBD 人群中流感疫苗接种率存在差异。
